Traws Pharma Inc (NAS:TRAW)
$ 0.4748 0.0088 (1.89%) Market Cap: 12.01 Mil Enterprise Value: -4.55 Mil PE Ratio: 0 PB Ratio: 1.64 GF Score: 49/100

Q1 2023 Onconova Therapeutics Inc Earnings Call Transcript

May 15, 2023 / 08:30PM GMT
Release Date Price: $1.18 (-5.60%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. (Operator Instructions) As a reminder, this call is being recorded today, May 15, 2023.

At this time, I would like to turn the call over to Bruce Mackle of LifeSci Advisors.

Bruce Mackle

Thank you, operator, and welcome, everyone, to Onconova's First Quarter 2023 Financial Results and Business Update Conference Call. Earlier this afternoon, Onconova issued a press release reporting its financial results and business progress. If you have not yet seen this press release, it is available in the Investors & Media section of the company's website at onconova.com.

Following my introduction, we will hear from Onconova's President and CEO; Dr. Steve Fruchtman; Interim Chief Medical Officer, Dr. Michael Saunders; and Chief Operating Officer and Chief Financial Officer, Mark Guerin. Onconova's VP of Regulatory Affairs and Quality Assurance, Fred Frullo, will also be available during the Q&A

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot